C.Q. Pharmaceutical Holding Co., Ltd. (000950.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 21Aug 26Aug 31Sep 3Sep 8Sep 11Sep 16Sep 21

Key dataSep 21, 2026

OpenCNY 5.21

From 52W high−24.23%

Volume22.97M

Market capCNY 9.27B

P/E (TTM)24.0x

P/S (TTM)0.1x

Div yield1.15%

Key dataSep 21, 2026

Open

CNY 5.21

From 52W high

−24.23%

Volume

22.97M

Market cap

CNY 9.27B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

30.3x

P/E (TTM)

24.0x

RSI (14)

42.3

MomentumView details →

1D Return

−1.28%

YTD Return

−10.48%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

24.0x

EV/EBITDA

30.3x

EV/Sales

0.4x

P/S (TTM)

0.1x

P/B (TTM)

0.8x

ProfitabilityView details →

Gross Margin

7.12%

Net Margin

0.53%

EBITDA Margin

1.24%

ROE (TTM)

3.69%

ROA (TTM)

0.63%

Asset Turnover

1.22x

GrowthView details →

Revenue YoY

+0.88%

EPS YoY

+41.60%

FCF YoY

—

Revenue CAGR 3Y

+6.72%

EPS CAGR 3Y

−26.32%

EBITDA YoY

—

MomentumView details →

1D Return

−1.28%

YTD Return

−10.48%

1Y Return

−0.19%

RSI (14)

42.3

vs 50D SMA

−4.51%

vs 200D SMA

−9.72%

Capital & dividendView details →

Debt/Equity

1.86x

Current Ratio

1.20x

Quick Ratio

1.00x

Div Yield

1.15%

Div Rate

CNY 0.06

Div Growth 1Y

+100.00%

EarningsView details →

EPS (Actual)

CNY 0.05

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

82.27B

Net Income (TTM)

432.21M

Op. CF (TTM)

−396.97M

Latest newsMore news →

Chongqing Pharmaceutical Holding Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 254 million yuan, down 9.85% year-on-year, with revenue of 40.132 billion yuan, down 2.57%.27d ago

Chongqing Pharmaceutical Holdings and its controlling subsidiaries have newly disclosed litigation and arbitration matters not previously disclosed within the past twelve months, with a total involved amount of 1.289 billion yuan, accounting for 11.17% of the company's most recent audited net assets attributable to the parent company.48d ago

Similar companies

泰恩康301263.SZ 步步高002251.SZ 雅创电子301099.SZ 建发致新301584.SZ 友阿股份002277.SZ 赛维时代301381.SZ Find similar companies →

Latest newsMore news →

Chongqing Pharmaceutical Holding Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 254 million yuan, down 9.85% year-on-year, with revenue of 40.132 billion yuan, down 2.57%.27d ago Chongqing Pharmaceutical Holdings and its controlling subsidiaries have newly disclosed litigation and arbitration matters not previously disclosed within the past twelve months, with a total involved amount of 1.289 billion yuan, accounting for 11.17% of the company's most recent audited net assets attributable to the parent company.48d ago